Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001490978-23-000095
Filing Date
2023-08-03
Accepted
2023-08-03 17:10:45
Documents
13
Period of Report
2023-08-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A sdgr-20230802.htm   iXBRL 8-K/A 29606
2 EX-99.1 sdgr-20230630xexx9911.htm EX-99.1 213475
  Complete submission text file 0001490978-23-000095.txt   399578

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sdgr-20230802.xsd EX-101.SCH 1913
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sdgr-20230802_lab.xml EX-101.LAB 25806
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sdgr-20230802_pre.xml EX-101.PRE 13577
7 EXTRACTED XBRL INSTANCE DOCUMENT sdgr-20230802_htm.xml XML 4124
Mailing Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036
Business Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036 503-299-1150
Schrodinger, Inc. (Filer) CIK: 0001490978 (see all company filings)

EIN.: 954284541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39206 | Film No.: 231141146
SIC: 2834 Pharmaceutical Preparations